Structure analysis of a heteropolysaccharide from Taraxacum mongolicum Hand.-Matz. and anticomplementary activity of its sulfated derivatives

被引:57
作者
Chen, MiaoMiao
Wu, Jianjun
Shi, Songshan
Chen, Yonglin
Wang, Huijun
Fan, Hongwei
Wang, Shunchun [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Inst Chinese Mat Med, 1200 Cailun Rd, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Polysaccharide; Taraxacum mongolicum Hand.-Mazz; Sulfated derivative; Structure-activity relationship; Anticomplement; HEPARIN-BINDING SITE; ANTICOAGULANT ACTIVITY; COMPLEMENT-SYSTEM; POLYSACCHARIDES; CHROMATOGRAPHY; ALGAE; ARABINOGALACTAN; LOCALIZATION; IMMUNITY; INHIBIT;
D O I
10.1016/j.carbpol.2016.06.110
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A homogenous water-soluble polysaccharide, DPSW-A, with a deduced chemical structure was extracted from the herb Taraxacum mongolicum Hand.-Mazz. Moreover, 80.813-kDa DPSW-A is composed of three types of monosaccharide, namely rhamnose, arabinose, and galactose, at a molar ratio of 1.0:10.7:11.9. The main chain of DPSW-A contains Terminal-Galp, 1,3-Galp, 1,6-Galp, 1,3,6-Galp, and 1,2,4-Rhap; the branched chain contains Terminal-Araf, 1,5-Araf, and 1,3,5-Araf. The sulfated derivatives prepared from DPSW-A showed inhibitory effects on complement activation through the classical pathway (CH50: Sul-DPSW-A, 3.94 +/- 0.43 mu g/mL; heparin, 104.40 +/- 3.82 mu g/mL) and alternative pathway (AP(50): Sul-DPSW-A, 42.76 +/- 0.46 mu g/mL; heparin, 43.42 +/- 0.22 mu g/mL). Mechanism studies indicated that Sul-DPSW-A inhibited complement activation by blocking C1q, C1r, C1s, and C9, but not C2, C3, C4, and C5. In addition, Sul-DPSW-A displayed limited anticoagulant effects. These results suggest that Sul-DPSW-A prepared from DPSW-A is valuable for treating diseases caused by excessive complement system activation. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:241 / 252
页数:12
相关论文
共 36 条
[1]   REQUIREMENT OF FREE CARBOXYL GROUPS FOR THE ANTICOAGULANT ACTIVITY OF HEPARIN [J].
AGARWAL, A ;
DANISHEFSKY, I .
THROMBOSIS RESEARCH, 1986, 42 (05) :673-680
[2]   Relationships between chemical characteristics and anticomplementary activity of fucans [J].
Blondin, C ;
Chaubet, F ;
Nardella, A ;
Sinquin, C ;
Jozefonvicz, J .
BIOMATERIALS, 1996, 17 (06) :597-603
[3]   The complement system in regulation of adaptive immunity [J].
Carroll, MC .
NATURE IMMUNOLOGY, 2004, 5 (10) :981-986
[4]   Conductivity detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans separated by high-performance size-exclusion chromatography [J].
Chaidedgumjorn, A ;
Suzuki, A ;
Toyoda, H ;
Toida, T ;
Imanari, T ;
Linhardt, RJ .
JOURNAL OF CHROMATOGRAPHY A, 2002, 959 (1-2) :95-102
[5]   An anti-complementary polysaccharide from the roots of Bupleurum chinense [J].
Di, Hongye ;
Zhang, Yunyi ;
Chen, Daofeng .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2013, 58 :179-185
[6]   Structure of a homofructosan from Saussurea costus and anti-complementary activity of its sulfated derivatives [J].
Fan, Hongwei ;
Liu, Fei ;
Bligh, S. W. Annie ;
Shi, Songshan ;
Wang, Shunchun .
CARBOHYDRATE POLYMERS, 2014, 105 :152-160
[7]   Structure and anticoagulant activity of sulfated galactans -: Isolation of a unique sulfated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action wtth that of sulfated galactans from invertebrates [J].
Farias, WRL ;
Valente, AP ;
Pereira, MS ;
Mourao, PAS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29299-29307
[8]   Relationship between sulfate groups and biological activities of fucans [J].
Haroun-Bouhedja, F ;
Ellouali, M ;
Sinquin, C ;
Boisson-Vidal, C .
THROMBOSIS RESEARCH, 2000, 100 (05) :453-459
[9]   STRUCTURAL DETERMINANTS OF THE CAPACITY OF HEPARIN TO INHIBIT THE FORMATION OF THE HUMAN AMPLIFICATION C3-CONVERTASE [J].
KAZATCHKINE, MD ;
FEARON, DT ;
METCALFE, DD ;
ROSENBERG, RD ;
AUSTEN, KF .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (01) :223-228
[10]   Controlling the complement system in inflammation [J].
Kirschfink, M .
IMMUNOPHARMACOLOGY, 1997, 38 (1-2) :51-62